Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2014

01-09-2014 | Cornea

Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients

Authors: Tohru Sakimoto, Takako Ohnishi, Akiko Ishimori

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 9/2014

Login to get access

Abstract

Background

We investigated the presence of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), proinflammatory cytokines, and soluble cytokine receptors in the tear fluid of patients with noninfectious corneal ulcers in the peripheral cornea.

Methods

The subjects were 20 eyes of 17 patients with peripheral noninfectious corneal ulcers and 20 eyes of 20 volunteers. Tear samples were taken by the Schirmer test I method and the presence of MMPs (MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, and MMP-13) and TIMPs (TIMP-1, TIMP-2, and TIMP-4) were investigated using an MMP antibody array system. The concentrations of proinflammatory cytokines {IL-1β, IL-6, and TNF-α (tumor necrosis factor-alpha)} and soluble cytokine receptors {soluble (s) IL-1R1, sIL-1R2, sIL-2Rα, sIL-4R, sIL-6R, sTNFR1, sTNFR2, s-vascular endothelial growth factor receptor (VEGFR) 1, sVEGFR2, sVEGFR3, and sgp130} were determined using the multiplex bead immunoassay system.

Results

The concentrations of MMP-8 and MMP-9 were significantly up-regulated in the tear fluid of the ulcer patients, whereas TIMPs concentrations did not change. The concentrations of IL-1β, IL-6, sIL-1R2, sIL-6R, sTNFR1, and sTNFR2 were up-regulated in the ulcer patients, whereas sgp130 and sVEGFR1 concentrations significantly decreased.

Conclusions

The presence of some MMPs increased significantly in the patients with peripheral noninfectious corneal ulcers, whereas the presence of TIMPs remained unchanged. Although some proinflammatory cytokines were up-regulated, their antagonists, soluble cytokine receptors, were also up-regulated. It is thus possible that the up-regulation of MMPs disrupts the balance between the MMPs and TIMPs and that this balance may play a pivotal role in the pathophysiology of corneal ulceration.
Literature
1.
go back to reference Dana MR, Qian Y, Hamrah P (2000) Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea 19:625–643PubMedCrossRef Dana MR, Qian Y, Hamrah P (2000) Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea 19:625–643PubMedCrossRef
2.
go back to reference Sivak JM, Fini ME (2002) MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 21:1–14PubMedCrossRef Sivak JM, Fini ME (2002) MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 21:1–14PubMedCrossRef
3.
go back to reference Gottsch JD, Liu SH, Minkovitz JB, Goodman DF, Srinivasan M, Stark WJ (1995) Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer. Invest Ophthalmol Vis Sci 36:1541–1547PubMed Gottsch JD, Liu SH, Minkovitz JB, Goodman DF, Srinivasan M, Stark WJ (1995) Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer. Invest Ophthalmol Vis Sci 36:1541–1547PubMed
4.
go back to reference Messmer EM, Foster CS (1999) Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 43:379–396PubMedCrossRef Messmer EM, Foster CS (1999) Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 43:379–396PubMedCrossRef
6.
go back to reference Jhanji V, Young AL, Mehta JS, Sharma N, Agarwal T, Vajpayee RB (2011) Management of corneal perforation. Surv Ophthalmol 56:522–538PubMedCrossRef Jhanji V, Young AL, Mehta JS, Sharma N, Agarwal T, Vajpayee RB (2011) Management of corneal perforation. Surv Ophthalmol 56:522–538PubMedCrossRef
7.
go back to reference Sakimoto T, Shoji J, Sawa M (2003) Active form of gelatinases in tear fluid in patients with corneal ulcer or ocular burn. Jpn J Ophthalmol 47:423–426PubMedCrossRef Sakimoto T, Shoji J, Sawa M (2003) Active form of gelatinases in tear fluid in patients with corneal ulcer or ocular burn. Jpn J Ophthalmol 47:423–426PubMedCrossRef
8.
go back to reference Shoji J, Inada N, Sawa M (2006) Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn J Ophthalmol 50:195–204PubMedCrossRef Shoji J, Inada N, Sawa M (2006) Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn J Ophthalmol 50:195–204PubMedCrossRef
9.
go back to reference Clark IM, Swingler TE, Sampieri CL, Edwards DR (2008) The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40:1362–1378PubMedCrossRef Clark IM, Swingler TE, Sampieri CL, Edwards DR (2008) The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40:1362–1378PubMedCrossRef
11.
go back to reference Toft-Hansen H, Nuttall RK, Edwards DR, Owens T (2004) Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 173:5209–5218PubMedCrossRef Toft-Hansen H, Nuttall RK, Edwards DR, Owens T (2004) Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 173:5209–5218PubMedCrossRef
12.
go back to reference Matsubara M, Zieske JD, Fini ME (1991) Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 32:3221–3237PubMed Matsubara M, Zieske JD, Fini ME (1991) Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 32:3221–3237PubMed
13.
go back to reference Takahashi H, Igarashi T, Fujimoto C, Ozaki N, Ishizaki M (2007) Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo. Jpn J Ophthalmol 51:3–9PubMedCrossRef Takahashi H, Igarashi T, Fujimoto C, Ozaki N, Ishizaki M (2007) Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo. Jpn J Ophthalmol 51:3–9PubMedCrossRef
14.
go back to reference Rose-John S, Heinrich PC (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300:281–290PubMedCentralPubMed Rose-John S, Heinrich PC (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300:281–290PubMedCentralPubMed
15.
go back to reference Zerler B (1991) The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 3:471–479PubMed Zerler B (1991) The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 3:471–479PubMed
16.
go back to reference McDermott MF (2001) TNF and TNFR biology in health and disease. Cell Mol Biol 47:619–635PubMed McDermott MF (2001) TNF and TNFR biology in health and disease. Cell Mol Biol 47:619–635PubMed
17.
go back to reference Beresford MW (2011) Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy. Paediatr Drugs 13:161–173PubMedCrossRef Beresford MW (2011) Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy. Paediatr Drugs 13:161–173PubMedCrossRef
18.
go back to reference Na KS, Mok JW, Kim JY, Rho CR, Joo CK (2012) Correlations between tear cytokines, Chemokines, and soluble receptors and clinical severity of Dry Eye disease. Invest Ophthalmol Vis Sci 53:5443–5450PubMedCrossRef Na KS, Mok JW, Kim JY, Rho CR, Joo CK (2012) Correlations between tear cytokines, Chemokines, and soluble receptors and clinical severity of Dry Eye disease. Invest Ophthalmol Vis Sci 53:5443–5450PubMedCrossRef
19.
go back to reference Bourke E, Cassetti A, Villa A, Fadlon E, Colotta F, Mantovani A (2003) IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils. J Immunol 170:5999–6005PubMedCrossRef Bourke E, Cassetti A, Villa A, Fadlon E, Colotta F, Mantovani A (2003) IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils. J Immunol 170:5999–6005PubMedCrossRef
20.
go back to reference Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443:993–997PubMedCentralPubMedCrossRef Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443:993–997PubMedCentralPubMedCrossRef
21.
go back to reference Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437:169–183PubMedCrossRef Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437:169–183PubMedCrossRef
Metadata
Title
Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients
Authors
Tohru Sakimoto
Takako Ohnishi
Akiko Ishimori
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 9/2014
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-014-2708-1

Other articles of this Issue 9/2014

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2014 Go to the issue